Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meletios-Athanasios Dimopoulos

Showing results (201-210 of 283) with videos related to

Pageof 29
Sort By:
Vaccines|October 26, 2021
Immunological Response to COVID-19 Vaccination in Ovarian Cancer Patients Receiving PARP InhibitorsMichalis Liontos, Evangelos Terpos, Christos Markellos, et al.
Prostate Cancer and Prostatic Diseases|October 10, 2021
Treatment with abiraterone or enzalutamide does not impair immunological response to COVID-19 vaccination in prostate cancer patientsMichalis Liontos, Evangelos Terpos, Elena Kunadis, et al.
Clinical Genitourinary Cancer|May 14, 2014
Prognostic significance of cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma treated with first-line sunitinib: a European multiinstitutional studyAristotle Bamias, Kimon Tzannis, Athanasios Papatsoris, et al.
Cancer Genomics & Proteomics|June 26, 2025
Serum Proteomic Signatures of Pregnancy-associated Breast CancerAnna-Maria Korakiti, Eleni Zografos, Stavros C Proikakis, et al.
Cancers|June 10, 2022
SARS-CoV-2 Neutralizing Antibodies Kinetics Postvaccination in Cancer Patients under Treatment with Immune Checkpoint InhibitionEvangelos Terpos, Michalis Liontos, Oraianthi Fiste, et al.
Breast (Edinburgh, Scotland)|September 4, 2021
SARS-CoV-2 neutralizing antibodies after first vaccination dose in breast cancer patients receiving CDK4/6 inhibitorsFlora Zagouri, Evangelos Terpos, Oraianthi Fiste, et al.
Journal of Clinical Medicine|April 12, 2025
Yearly Assessment of Bone Disease in Patients with Asymptomatic Multiple Myeloma Identifies Early Progression Events and Should Be the Standard Clinical PracticeIoannis Ntanasis-Stathopoulos, Vassilis Koutoulidis, Panagiotis Malandrakis, et al.
Haematologica|July 7, 2019
A real world multicenter retrospective study on extramedullary disease from Balkan Myeloma Study Group and Barcelona University: analysis of parameters that improve outcomeMeral Beksac, Guldane Cengiz Seval, Nicholas Kanellias, et al.
Journal of Translational Medicine|April 6, 2023
miRNA-seq identification and clinical validation of CD138+ and circulating miR-25 in treatment response of multiple myelomaMaria-Alexandra Papadimitriou, Konstantinos Soureas, Aristea-Maria Papanota, et al.
Leukemia & Lymphoma|September 1, 2023
Impact of daratumumab on stem cell mobilization and collection, engraftment and early post-transplant complications among multiple myeloma patients undergoing autologous stem cell transplantationEvangelos Eleutherakis Papaiakovou, Evangelos Terpos, Nikolaos Kanellias, et al.
Pageof 29

Showing results (201-210 of 283) with videos related to

Sort By:
Pageof 29
Vaccines|October 26, 2021
Immunological Response to COVID-19 Vaccination in Ovarian Cancer Patients Receiving PARP InhibitorsMichalis Liontos, Evangelos Terpos, Christos Markellos, et al.
Prostate Cancer and Prostatic Diseases|October 10, 2021
Treatment with abiraterone or enzalutamide does not impair immunological response to COVID-19 vaccination in prostate cancer patientsMichalis Liontos, Evangelos Terpos, Elena Kunadis, et al.
Clinical Genitourinary Cancer|May 14, 2014
Prognostic significance of cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma treated with first-line sunitinib: a European multiinstitutional studyAristotle Bamias, Kimon Tzannis, Athanasios Papatsoris, et al.
Cancer Genomics & Proteomics|June 26, 2025
Serum Proteomic Signatures of Pregnancy-associated Breast CancerAnna-Maria Korakiti, Eleni Zografos, Stavros C Proikakis, et al.
Cancers|June 10, 2022
SARS-CoV-2 Neutralizing Antibodies Kinetics Postvaccination in Cancer Patients under Treatment with Immune Checkpoint InhibitionEvangelos Terpos, Michalis Liontos, Oraianthi Fiste, et al.
Breast (Edinburgh, Scotland)|September 4, 2021
SARS-CoV-2 neutralizing antibodies after first vaccination dose in breast cancer patients receiving CDK4/6 inhibitorsFlora Zagouri, Evangelos Terpos, Oraianthi Fiste, et al.
Journal of Clinical Medicine|April 12, 2025
Yearly Assessment of Bone Disease in Patients with Asymptomatic Multiple Myeloma Identifies Early Progression Events and Should Be the Standard Clinical PracticeIoannis Ntanasis-Stathopoulos, Vassilis Koutoulidis, Panagiotis Malandrakis, et al.
Haematologica|July 7, 2019
A real world multicenter retrospective study on extramedullary disease from Balkan Myeloma Study Group and Barcelona University: analysis of parameters that improve outcomeMeral Beksac, Guldane Cengiz Seval, Nicholas Kanellias, et al.
Journal of Translational Medicine|April 6, 2023
miRNA-seq identification and clinical validation of CD138+ and circulating miR-25 in treatment response of multiple myelomaMaria-Alexandra Papadimitriou, Konstantinos Soureas, Aristea-Maria Papanota, et al.
Leukemia & Lymphoma|September 1, 2023
Impact of daratumumab on stem cell mobilization and collection, engraftment and early post-transplant complications among multiple myeloma patients undergoing autologous stem cell transplantationEvangelos Eleutherakis Papaiakovou, Evangelos Terpos, Nikolaos Kanellias, et al.
Pageof 29